The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. C4 Therapeutics Inc shares valued at $2,107 were sold by Boyle Scott N on Feb 18 ’25. At $3.15 per share, Boyle Scott N sold 669 shares. The insider’s holdings dropped to 107,805 shares worth approximately $0.32 million following the completion of this transaction.
Also, Boyle Scott N sold 490 shares, netting a total of over 1,544 in proceeds. Following the sale of shares at $3.15 each, the insider now holds 110,842 shares.
Before that, Salter Malcolm had added 13,000 shares to its account. In a trade valued at $54,532, the Director bought C4 Therapeutics Inc shares for $4.19 each.
As published in a research note from Wells Fargo on December 19, 2024, C4 Therapeutics Inc [CCCC] has been rated up from an Equal weight to an Overweight and the price target has been revised to $12 from $8. Analysts at Stephens started covering the stock with ‘”an Equal-weight”‘ outlook in a report released in mid November. As of January 29, 2024, JP Morgan has increased its “an Underweight” rating to a “Neutral” for CCCC. Earlier on December 13, 2023, Stifel upgraded its rating. Their new recommendation was “a Buy” for CCCC stock which previously was a “a Hold”.
Analyzing CCCC Stock Performance
During the last five days, there has been a drop of approximately -7.95%. Over the course of the year, C4 Therapeutics Inc shares have dropped approximately -16.39%. Shares of the company reached a 52-week high of $4.26 on 01/06/25 and a 52-week low of $2.87 on 02/19/25. A 50-day SMA is recorded $3.76, while a 200-day SMA reached $5.15. Nevertheless, trading volume fell to 1.25 million shares from 1.85 million shares the previous day.
Support And Resistance Levels for C4 Therapeutics Inc (CCCC)
According to the 24-hour chart, there is a support level at 2.89, which, if violated, would cause prices to drop to 2.77. In the upper region, resistance lies at 3.11. The next price resistance is at 3.22. RSI (Relative Strength Index) is 33.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.30, which suggests the price will decrease in the coming days. Percent R is at 85.57%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
